Skip to main content
. 2019 Feb 23;6:106–112. doi: 10.1016/j.ejro.2019.02.005

Table 2.

Baseline and clinical data of 33 included patients.

Serial Gender Age(y) Lesion number Arterial phase enhancement Diameter (mm) Washout Capsule LR score DSA Follow-up examination Follow-up time size Lipiodol deposit
1 F 64 2 hyper-, hypo-/iso- 11, 11 n, n n, n 3, 3 n, n CT 4months →, → n, n
2 M 56 2 hyper- 27, 22 n, y n, y 4, 5 n, p CT 2months ↓,↓ n, y
3 M 61 3 hypo-/iso-, hypo-/iso-, hypo-/iso- 11, 9, 8 n, n, n n, n, n 3, 3, 3 n, n, n CT, MRI 7months →, →→ n, n, n
4 F 43 3 hyper-, hyper-, hyper- 11, 10, 9 n, n, n n, n, n 3, 3, 3 n, n, n CT, MRI 2months →, →, → n, n, n
5 M 73 3 hyper-, hyper-, hypo-/iso- 21, 31, 34 y, y, n y, n, n 5, 5, 3 p, p, p CT 3months ↑,→,→ n, y, n
6 M 29 1 hyper- 31 y n 5 p CT 3months y
7 M 46 1 hyper- 27 y y 5 p CT 1 month y
8 M 43 3 hyper- 14, 14, 11 n, n, n n, n, n 3, 3, 3 p, p, p CT 2months →, →, → y, n, n
9 M 54 1 hyper- 40 y y 5 p CT 2months y
10 M 38 3 hypo-/iso- 11, 14, 18 n, n, n n, n, n 3 n, n, n CT 2months →, →, → n, n, n
11 M 40 1 hyper- 8 y n 4 n MRI 1months y
12 M 52 3 hyper- 93, 36, 25 y, y, y y, y, y 5, 5, 5 p, p, n CT 1month ↑, ↑, ↑ y, n, n
13 F 53 3 hyper-, hyper-, hypo-/iso- 7, 7, 7 n, n, n n, n, n 3, 3, 3 n, p, n CT 2months →, →, → n, y, n
14 F 58 3 hyper-, hyper-, hyper- 7, 16, 37 y, y, y y, y, y 4, 5, 5 p, p, p CT 2months →, →, → y, y, y
15 M 58 1 hypo-/iso- 16 n n 3 n CT 2months n
16 M 71 3 hyper-, hyper-, hyper- 21, 16, 10 y, y, n y, y, n 5, 5, 4 p, p, p CT 2months →, →, → y, y, y
17 F 42 1 hyper- 83 y y 5 p CT 2months y
18 M 63 3 hyper-, hypo-/iso-, hypo-/iso- 30, 12, 13 y, n, n y, y, n 5, 3, 3 p, p, p CT, MRI 1month ↓, ↓, ↓ y, y, n
19 M 75 3 hyper- 13, 10, 8 n, n, n n, n, n 3, 3, 3 p, p, p CT 2months ↓, ↓, ↓ y, y, n
20 M 57 1 hypo-/iso- 16 n n 3 n CT 1 month n
21 M 41 2 hypo-/iso- 10, 8 n, n n, n 3, 3 n, n CT 2months →, → n, n
22 M 50 1 hypo-/iso- 9 y y 4 p CT 2months y
23 M 37 3 hyper- 47, 11, 9 y, y, y y, y, y 5, 5, 4 p, p, p CT 2months ↓,↓,↓ y, y, y
24 M 50 3 hypo-/iso- 10, 10, 9 n, n, n n, n, n 3, 3, 3 n, n, n CT, MRI 11months →, →,→ n, n, n
25 M 69 3 hyper-, hypo-/iso-, hypo-/iso- 42, 27, 12 n, n, n n, n, n 5, 3, 3 p, p, p CT 2months ↓, ↓,↓ y, y, y
26 M 59 1 hyper- 70 y n 5 p CT 1month y
27 M 45 3 hyper- 33, 15, 15 y, y, n n, y, n 5, 4, 3 p, p, p CT 10months ↓,↑,→ y, y, n
28 M 38 3 hypo-/iso- 18, 11, 11 n, n, n n, n, n 3, 3, 3 n, n, n CT 1months →, →, → n, n, n
29 F 43 2 hypo-/iso- 8,5 n, n n, n 3, 3 n, n CT 2months →, → y, n
30 M 44 1 hyper- 14 y n 4 p CT 1month y
31 F 63 1 hyper- 15 n n 3 p CT, MRI 2months y
32 M 44 1 hyper- 26 n y 5 p CT 2months y
33 M 41 3 hyper- 83, 22, 16 y, y, y n, n, n 5, 5, 4 p, p, p CT 1 month →, →, → y, y, y

M: Male; F: Female; y: yes; n: no; p: positive, n (column DSA): negative; ↑: size increase; ↓: size decrease; →: size remain stable.